A Lahiri Selected Research

Cardiomyopathies (Cardiomyopathy)

3/2001

Role of dobutamine echocardiography in detection of myocardial viability for predicting outcome after revascularization in ischemic cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Lahiri Research Topics

Disease

6	Myocardial Infarction 04/2018 - 02/2001
6	Heart Failure 11/2004 - 01/2000
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012 - 02/2000
4	Left Ventricular Dysfunction 12/2004 - 12/2000
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2012 - 10/2003
2	Coronary Disease (Coronary Heart Disease) 01/2012 - 07/2009
2	Type 2 Diabetes Mellitus (MODY) 01/2012 - 07/2009
2	Acute Coronary Syndrome 10/2003 - 02/2000
2	Stable Angina 09/2001 - 01/2000
1	Long QT Syndrome 01/2022
1	Vomiting 01/2022
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Ischemic Stroke 04/2018
1	ST Elevation Myocardial Infarction 04/2018
1	Hemorrhage 04/2018
1	Cardiogenic Shock 04/2018
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2012
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2009
1	Atherosclerosis 07/2009
1	Death (Near-Death Experience) 07/2006
1	Obesity 03/2006
1	Ectrodactyly-cleft lip-palate syndrome 01/2006
1	Breast Neoplasms (Breast Cancer) 01/2006
1	Necrosis 10/2003
1	Unstable Angina 10/2003
1	Ventricular Remodeling 10/2001
1	Edema (Dropsy) 09/2001
1	Tuberculosis (Tuberculoses) 08/2001
1	Cardiomyopathies (Cardiomyopathy) 03/2001
1	Pathologic Constriction (Stenosis) 02/2001
1	Chest Pain (Chest Pains) 02/2000

Drug/Important Bio-Agent (IBA)

3	CalciumIBA 01/2012 - 01/2000
3	Radioisotopes (Radionuclides)IBA 12/2004 - 08/2000
3	Carvedilol (Coreg)FDA LinkGeneric 07/2004 - 10/2001
2	ApolipoproteinsIBA 01/2012 - 07/2009
2	Biomarkers (Surrogate Marker)IBA 07/2009 - 10/2003
2	TroponinIBA 10/2003 - 02/2000
2	Diltiazem (Cardizem)FDA LinkGeneric 09/2001 - 01/2000
2	Contrast MediaIBA 12/2000 - 02/2000
1	ElectrolytesIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2012
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2012
1	Advanced Glycation End ProductsIBA 01/2012
1	AntibodiesIBA 01/2012
1	AntigensIBA 07/2009
1	AutoantibodiesIBA 07/2009
1	Peptides (Polypeptides)IBA 07/2009
1	Apolipoprotein B-100 (Apo B 100)IBA 07/2009
1	oxidized low density lipoproteinIBA 07/2009
1	low density lipoprotein inhibitorIBA 07/2009
1	omega-Chloroacetophenone (Mace)IBA 07/2006
1	Indicators and Reagents (Reagents)IBA 03/2006
1	diclofenac hydroxyethylpyrrolidine (DIEP)FDA Link 01/2006
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2004
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2001
1	Captopril (Capoten)FDA LinkGeneric 10/2001
1	Amlodipine (Norvasc)FDA LinkGeneric 09/2001
1	TabletsIBA 09/2001
1	AcidsIBA 08/2001
1	Tuberculin (PPD)IBA 08/2001
1	Dobutamine FDA LinkGeneric 03/2001
1	Vasodilator Agents (Vasodilators)IBA 02/2001
1	Dipyridamole (Persantine)FDA LinkGeneric 02/2001
1	contrast agent BR1IBA 02/2000
1	antineoplaston A10 (A 10)IBA 01/2000
1	Nifedipine (Adalat)FDA LinkGeneric 01/2000
1	DihydropyridinesIBA 01/2000

Therapy/Procedure

3	Therapeutics 04/2018 - 01/2000
1	Length of Stay 04/2018
1	Percutaneous Coronary Intervention 04/2018
1	Perforator Flap 01/2006
1	Mammaplasty (Breast Reconstruction) 01/2006
1	Intravenous Injections 02/2000